Clough Global Opportunities Fundの収益はセグメントまたは地域別にどのように分けられていますか?
PomDoctor Ltd の最大収益セグメントは Medicines for Childhood and Adult Diseases with Equal Intensity で、最新の利益発表における収益は 131,161,000 です。地域別に見ると、United States が PomDoctor Ltd の主要市場であり、収益は 131,161,000 です。
Clough Global Opportunities Fundは収益を上げていますか?
いいえ、最新の財務諸表によると、PomDoctor Ltdの純損失は$-143です。
Clough Global Opportunities Fundに負債はありますか?
はい、PomDoctor Ltdの負債は714です。
Clough Global Opportunities Fundの発行済株式数は何株ですか?
PomDoctor Ltdの総発行済株式数は0株です。
主要データ
前終値
$5.57
始値
$5.51
当日レンジ
$5.46 - $5.59
52週レンジ
$4.32 - $6.09
取引高
153.1K
平均取引高
219.4K
配当利回り
--
1株当たり利益(TTM)
--
時価総額
$238.6M
GLOとは何ですか?
Clough Global Opportunities Fund is a US-based company operating in industry. The company is headquartered in Denver, Colorado. The company went IPO on 2006-04-26. Clough Global Opportunities Fund (the Fund) is a closed-end management investment company. The Fund’s investment objective is to provide a high level of total return. The company seeks to achieve its objective by applying a fundamental research-driven investment process. The Fund invests primarily in a managed mix of equity securities. Its investment portfolio includes common stocks, preferred stocks, corporate bonds, convertible corporate bonds, and asset-backed securities. The company invests in various sectors, such as consumer discretionary, energy, financials, healthcare, industrials, information technology, real estate, and communications services. The Fund holds investments in various countries, including the United States, China, France, Germany, Switzerland, Canada, and Hong Kong. The investment advisor of the Fund is Clough Capital Partners L.P.